Clinical Trials Directory

Trials / Completed

CompletedNCT03456557

The Use of Perfusion CT Derived Parameters as Early Acute Pancreatitis Severity Biomarker Compared to Clinico Biological Score

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
15 (actual)
Sponsor
Poitiers University Hospital · Academic / Other
Sex
All
Age
18 Years – 100 Years
Healthy volunteers
Not accepted

Summary

The investigators to establish whether early microvascular permeability parameter evaluated by perfusion-CT could be good biomarkers for severity in acute pancreatitis. Therefore the investigators want to compare 48 hours-clinico-biological systemic inflammatory response syndrome score to initial microvascular permeability parameters ( ktrans - capillary membrane permeability factor- and pancreatic blood flow ) calculated by OLEA software using inclusion perfusion CT.

Conditions

Interventions

TypeNameDescription
RADIATIONPerfusion computed tomography.Using specific post treatment imaging software ( Olea® ) we will calculatell permeability parameters : the pancreatic blood flow and the k-trans, capillary membrane permeability factor.

Timeline

Start date
2018-03-07
Primary completion
2018-12-09
Completion
2018-12-09
First posted
2018-03-07
Last updated
2020-04-14

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT03456557. Inclusion in this directory is not an endorsement.